» Articles » PMID: 32001727

The Critical Role of Glucose Deprivation in Epithelial-mesenchymal Transition in Hepatocellular Carcinoma Under Hypoxia

Overview
Journal Sci Rep
Specialty Science
Date 2020 Feb 1
PMID 32001727
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Imaging with 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is used to determine sites of abnormal glucose metabolism to predict high tumor grade, metastasis, and poor patient survival. However, not all tumors with increased 18F-FDG uptake show aggressive tumor biology, as evident from the moderate correlation between metastasis and high FDG uptake. We hypothesized that metastasis is likely attributable to the complexity and heterogeneity of the cancer microenvironment. To identify the cancer microenvironment that induces the epithelial-mesenchymal transition (EMT) process, tumor areas of patients with HCC were analyzed by immunostaining. Our data demonstrated the induction of EMT process in HCC cells with low proliferation under hypoxic conditions. To validate our finding, among HCC cell lines, HepG2 cells with highly increased expression of HIF1α under hypoxia were employed in vitro and in vivo. Major changes in EMT-associated protein expression, such as the up-regulation of N-cadherin and snail/slug are associated with decreased proliferation-related protein (PCNA) caused by glucose deprivation under hypoxia. Indeed, PCNA knockdown-HepG2 cells under hypoxia showed the induction of more EMT process compare to the control. Thus, HCC cells with low proliferative potential under glucose-deprived and hypoxic conditions show high probability for induced EMT process and promote cell invasion. This study investigates reasons as to why an EMT process cannot fully be predicted. Our observations indicate that rather than analyzing a single factor, an integrated analysis of hypoxia with low glucose metabolism and low cell proliferation might be helpful to predict the potential impact on induction of EMT process and promotion of cell invasion.

Citing Articles

Macro- and micro-nutrient-based multiplex stress conditions modulate in vitro tumorigenesis and aggressive behavior of breast cancer spheroids.

Gayan S, Teli A, Nair A, Tomar G, Dey T In Vitro Model. 2025; 1(1):85-101.

PMID: 39872971 PMC: 11756478. DOI: 10.1007/s44164-021-00006-5.


The impact of epithelial-mesenchymal transition (EMT) induced by metabolic processes and intracellular signaling pathways on chemo-resistance, metastasis, and recurrence in solid tumors.

Liaghat M, Ferdousmakan S, Mortazavi S, Yahyazadeh S, Irani A, Banihashemi S Cell Commun Signal. 2024; 22(1):575.

PMID: 39623377 PMC: 11610171. DOI: 10.1186/s12964-024-01957-4.


Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution.

Zhang F, Ma Y, Li D, Wei J, Chen K, Zhang E J Hematol Oncol. 2024; 17(1):80.

PMID: 39223656 PMC: 11367794. DOI: 10.1186/s13045-024-01600-2.


Characterizing Metabolic Heterogeneity of Hepatocellular Carcinoma with Hyperpolarized C Pyruvate MRI and Mass Spectrometry.

Dou Q, Grant A, Coutinto de Souza P, Moussa M, Nasser I, Ahmed M Radiol Imaging Cancer. 2024; 6(2):e230056.

PMID: 38426887 PMC: 10988335. DOI: 10.1148/rycan.230056.


The application of F-FDG PET/CT imaging for human hepatocellular carcinoma: a narrative review.

Yao Y, Civelek A, Li X Quant Imaging Med Surg. 2023; 13(9):6268-6279.

PMID: 37711813 PMC: 10498267. DOI: 10.21037/qims-22-1420.


References
1.
Cleary S, Jeck W, Zhao X, Chen K, Selitsky S, Savich G . Identification of driver genes in hepatocellular carcinoma by exome sequencing. Hepatology. 2013; 58(5):1693-702. PMC: 3830584. DOI: 10.1002/hep.26540. View

2.
Mueller-Klieser W . Tumor biology and experimental therapeutics. Crit Rev Oncol Hematol. 2000; 36(2-3):123-39. DOI: 10.1016/s1040-8428(00)00082-2. View

3.
Sugiyama M, Sakahara H, Torizuka T, Kanno T, Nakamura F, Futatsubashi M . 18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma. J Gastroenterol. 2004; 39(10):961-8. DOI: 10.1007/s00535-004-1427-5. View

4.
Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad I . Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet. 2012; 44(6):694-8. PMC: 3819251. DOI: 10.1038/ng.2256. View

5.
Daskalow K, Rohwer N, Raskopf E, Dupuy E, Kuhl A, Loddenkemper C . Role of hypoxia-inducible transcription factor 1alpha for progression and chemosensitivity of murine hepatocellular carcinoma. J Mol Med (Berl). 2010; 88(8):817-27. DOI: 10.1007/s00109-010-0623-4. View